Boston Scientific (BSX) Raw Materials (2009 - 2026)

Boston Scientific has disclosed Raw Materials across 18 years of filings, most recently posting $985.0 million for Q2 2026.

• In Q2 2026, Raw Materials rose 17.96% year-over-year to $985.0 million; the TTM figure through Jun 2026 stood at $985.0 million (up 17.96% YoY), while the FY2025 annual figure was $849.0 million, up 3.66% from the prior year.
• Raw Materials came in at $985.0 million for Q2 2026 at Boston Scientific, up from $928.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $985.0 million in Q2 2026 to a low of $499.0 million in Q1 2022.
• Average Raw Materials over 5 years is $756.7 million, with a median of $818.5 million recorded in 2024.
• Year-over-year, Raw Materials jumped 41.09% in 2023 and decreased 1.65% in 2025.
• Over 5 years, Raw Materials stood at $548.0 million in 2022, then jumped by 41.06% to $773.0 million in 2023, then rose by 5.95% to $819.0 million in 2024, then gained by 3.66% to $849.0 million in 2025, then gained by 16.02% to $985.0 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $985.0 million in Q2 2026, $928.0 million in Q1 2026, and $849.0 million in Q4 2025.